Infliximab Archives - Medical Conferences

Recapturing remission in UC with subcutaneous infliximab

Presented By

Dr Kyuwon Kim, Chung-Ang University Hospital, South Korea

Conference

DDW 2025

Type

News article

21 May 2025 12:34

Therapeutic antibody clearance reliable predictor for endoscopic outcomes in CD

Presented By

Dr Erwin Dreesen, KU Leuven, Belgium

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 11:46

A paradigm shift in CD clinical practice

Presented By

Dr Nuru Noor, University of Cambridge, UK

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:24

Biologics in psoriatic arthritis: where we are and where we are headed

Presented By

Dr Vinod Chandran

Conference

IFPA 2024

Type

News article

17 July 2024 11:55

Biologicals and JAK inhibitors hold promise in microscopic colitis

Presented By

Dr Bram Verstockt, University Hospitals Leuven, Belgium

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:35

How effective is dose escalation of biologicals in IBD?

Presented By

Dr Cristina Rubín de Célix, University Hospital La Princesa, Spain

Trial

RAINBOW-IBD

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:30

Subcutaneous infliximab shows promise in UK IBD study

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 15:16

Anti-TNF withdrawal may be a safe option in stable IBD

Presented By

Prof. María Chaparro Sánchez , Hospital Universitario de La Princesa, Spain

Trial

Phase 4, EXIT

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 16:12

High retention rates after switching between infliximab biosimilars

Presented By

Dr Hafsah Nabi, Rigshospitalet, Denmar

Conference

ACR 2022

Type

News article

1 December 2022 14:21

Early biologic therapy induces larger effect than delayed treatment in Crohn’s disease

Presented By

Prof. Shomron Ben-Horin, Tel-Aviv University, Israel

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 17:21

Positive outcomes with therapeutic drug monitoring during infliximab maintenance therapy

Presented By

Dr Kristin Jørgensen, Akershus University Hospital, Norway

Trial

NOR-DRUM B

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 17:14

Similar results for different corticosteroid tapering protocols in UC

Presented By

Ms Pernille Ovesen, Herlev University Hospital, Denmark

Trial

SCOTCH

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 17:04

Stopping infliximab but not antimetabolites leads to more relapses in Crohn’s disease

Presented By

Prof. Edouard Louis, University Hospital Liège, Belgium

Trial

Phase 4, SPARE

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:55

Anti-TNFs versus vedolizumab and ustekinumab in Crohn’s disease

Presented By

Dr Neeraj Narula, McMaster University, Canada

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:46

Upadacitinib appears to be an efficacious therapy for moderately-to-severely ulcerative colitis

Presented By

Prof. Remo Panaccione , University of Calgary, Canada

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:44

Subcutaneous infliximab versus subcutaneous vedolizumab in IBD

Presented By

Prof. Laurent Peyrin-Biroulet, Nancy University Hospital, France

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:41

ECCO 2022 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ECCO 2022

8 March 2022 10:18

Blood proteins predicting relapse in CD identified

Presented By

Mr Nicolas Pierre, University of Liège, Belgium

Trial

Cohort study, STORI

Conference

ECCO 2021

Type

News article

2 July 2021 23:48

Risk of hospitalisation and surgery linked to IBD biological

Presented By

Dr Camilla Bjørn Jensen, Frederiksberg Hospital

Conference

ECCO 2021

Type

News article

2 July 2021 20:20

Infliximab for IBD may blunt antibody responses to SARS-CoV-2

Journal

Gut

23 March 2021 18:30

Rheumatoid arthritis: new EULAR treatment guidelines

Presented By

Prof. Daniel Aletaha, Medical University Vienna, Austria

Trial

IDEA, NORD-STAR

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 11:00

Biologics in HS – a growing armamentarium

Presented By

Prof. Joslyn Kirby, Penn State University, USA

Trial

PIONEER

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 12:48

Psoriasis therapy for children and pregnancies

Presented By

Prof. Mark Lebwohl, Icahn School of Medicine at Mount Sinai, USA

Trial

CRIB, CADMUS, IXORA-PEDS

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 08:03

Vedolizumab and anti-TNF therapies: a real-world comparison

Presented By

Dr G. Mantzaris , Evangelismos Hospital, Greece

Trial

EVOLVE

Conference

ECCO 2020

Type

Peer-reviewed article

14 April 2020 15:35

Vedolizumab, adalimumab, and golimumab compared

Presented By

Dr F.S. Macaluso & Dr A. Casanotti

Conference

ECCO 2020

Type

Peer-reviewed article

14 April 2020 15:32

Early ileocaecal resection in CD patients failing conventional treatment

Presented By

Dr T. Stevens, Amsterdam UMC, the Netherlands

Trial

LIR!C

Conference

ECCO 2020

Type

Peer-reviewed article

14 April 2020 15:11

Top-down infliximab superior to step-up in children with CD

Presented By

Dr M. Jongsma, Erasmus MC, the Netherlands

Conference

ECCO 2020

Type

Peer-reviewed article

14 April 2020 14:59

Infliximab discontinuation increases relapse risk

Presented By

Kobayashi T, Kitasato University, Japan

Conference

ECCO 2020

Type

Peer-reviewed article

14 April 2020 14:41

Lowest risk of infection after therapy with an IL-12/IL-23 blocker

Presented By

Dr Yinzhu Jin, Brigham and Women´s Hospital and Harvard Medical School, Boston, USA

Trial

Cohort study

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 23:42

Practice-changing: infliximab in children with Crohn’s

Trial

TISKids

Conference

UEGW 2019

Type

Peer-reviewed article

23 October 2019 23:42

Switching among multiple infliximab biosimilars does not cause immunogenicity

Presented By

Dr Jéróme Avouac, Paris Descartes University, France

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 12:06

Switching infliximab biosimilars safe in treating chronic plaque psoriasis

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 16:26

Efficacy and safety of biosimilars

Trial

CONNECT-IBD and SPOSIB SB2

Conference

ECCO 2019

Type

Peer-reviewed article

9 May 2019 19:35

Infliximab retreatment in luminal Crohn’s disease

Conference

ECCO 2019

Type

Peer-reviewed article

9 May 2019 18:36

ZNF133 associated with infliximab response

Conference

ECCO 2019

Type

Peer-reviewed article

9 May 2019 17:50

Biologic drug levels and infection risk, and clinical effectiveness of sarilumab

Trial

TARGET

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 19:30

Higher colectomy rate with infliximab vs conventional therapies in more severe UC

Conference

ECCO 2018

Type

Peer-reviewed article

28 May 2018 22:50